165 related articles for article (PubMed ID: 33096476)
1. Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Scholl SM; Beal J; de Koning L; Girard E; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Ngo C; Floquet A; Berns EM; Kenter G; Gestraud P; von der Leyen H; Lecerf C; Puard V; Roman SR; Latouche A; Kereszt A; Balint B; Rouzier R; Kamal M
EBioMedicine; 2020 Nov; 61():103049. PubMed ID: 33096476
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome.
Scholl S; Popovic M; de la Rochefordiere A; Girard E; Dureau S; Mandic A; Koprivsek K; Samet N; Craina M; Margan M; Samuels S; Zijlmans H; Kenter G; Hillemanns P; Dema S; Dema A; Malenkovic G; Djuran B; Floquet A; Garbay D; Guyon F; Colombo PE; Fabbro M; Kerr C; Ngo C; Lecuru F; Campo ERD; Coutant C; Marchal F; Mesgouez-Nebout N; Fourchotte V; Feron JG; Morice P; Deutsch E; Wimberger P; Classe JM; Gleeson N; von der Leyen H; Minsat M; Dubot C; Gestraud P; Kereszt A; Nagy I; Balint B; Berns E; Jordanova E; Saint-Jorre N; Savignoni A; Servant N; Hupe P; de Koning L; Fumoleau P; Rouzier R; Kamal M
EBioMedicine; 2019 May; 43():253-260. PubMed ID: 30952619
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localizaiton of β-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer.
Zhang Y; Liu B; Zhao Q; Hou T; Huang X
Int J Clin Exp Pathol; 2014; 7(7):3908-17. PubMed ID: 25120767
[TBL] [Abstract][Full Text] [Related]
4. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
5. REST-repressed lncRNA NPPA-AS1 regulates cervical cancer progression by modulating miR-302e/DKK1/Wnt/β-catenin signaling pathway.
Luan Y; Xie B; Wei W
J Cell Biochem; 2021 Jan; 122(1):16-28. PubMed ID: 32965043
[TBL] [Abstract][Full Text] [Related]
6. NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.
Wang Q; Qin Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Zhou D; He J
Cell Death Dis; 2018 Jun; 9(6):668. PubMed ID: 29867145
[TBL] [Abstract][Full Text] [Related]
7. From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer.
Ngo C; Samuels S; Bagrintseva K; Slocker A; Hupé P; Kenter G; Popovic M; Samet N; Tresca P; von der Leyen H; Deutsch E; Rouzier R; Belin L; Kamal M; Scholl S;
BMC Cancer; 2015 Nov; 15():842. PubMed ID: 26531748
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Zammataro L; Lopez S; Bellone S; Pettinella F; Bonazzoli E; Perrone E; Zhao S; Menderes G; Altwerger G; Han C; Zeybek B; Bianchi A; Manzano A; Manara P; Cocco E; Buza N; Hui P; Wong S; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Angioli R; Raspagliesi F; Scambia G; Choi J; Dong W; Bilguvar K; Alexandrov LB; Silasi DA; Huang GS; Ratner E; Azodi M; Schwartz PE; Pirazzoli V; Stiegler AL; Boggon TJ; Lifton RP; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22730-22736. PubMed ID: 31624127
[TBL] [Abstract][Full Text] [Related]
10. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
11. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapy.
Bohr Mordhorst L; Ahlin C; Sorbe B
Oncotarget; 2016 Sep; 7(39):63042-63053. PubMed ID: 27577083
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
14. WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition.
Zhou Y; Huang Y; Cao X; Xu J; Zhang L; Wang J; Huang L; Huang S; Yuan L; Jia W; Yu X; Luo R; Zheng M
PLoS One; 2016; 11(8):e0160414. PubMed ID: 27513465
[TBL] [Abstract][Full Text] [Related]
15. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
[TBL] [Abstract][Full Text] [Related]
16. RAIDS atlas of significant genetic and protein biomarkers in cervical cancer.
Scholl S; Roufai DB; Chérif LL; Kamal M
J Gynecol Oncol; 2023 Sep; 34(5):e74. PubMed ID: 37668079
[TBL] [Abstract][Full Text] [Related]
17.
Liang J; Zhou H; Peng Y; Xie X; Li R; Liu Y; Xie Q; Lin Z
Biomed Res Int; 2016; 2016():4923903. PubMed ID: 27843945
[TBL] [Abstract][Full Text] [Related]
18. CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR-153-3p/ATF2 axis and wnt/β-catenin pathway.
Wang Q; Xu B; Liu H; Wang D; Liu S; He C; Feng X; Wang L
Drug Dev Res; 2022 May; 83(3):755-768. PubMed ID: 34981843
[TBL] [Abstract][Full Text] [Related]
19. N
Lin X; Wang F; Chen J; Liu J; Lin YB; Li L; Chen CB; Xu Q
Mil Med Res; 2022 Apr; 9(1):19. PubMed ID: 35418160
[TBL] [Abstract][Full Text] [Related]
20. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
